Febrile Neutropenia Symptoms, Doctors, Treatments, Advances & More

Learn About Febrile Neutropenia

What is the definition of Febrile Neutropenia?

Febrile neutropenia, also called neutropenic fever, is a condition in which an individual has a fever greater than or equal to 101° F for at least an hour and a low neutrophil count. This is usually due to an infection. Febrile neutropenia commonly occurs as a complication in patients with cancer who are undergoing chemotherapy.

Save information for later

What are the symptoms of Febrile Neutropenia?

Symptoms of febrile neutropenia include a fever greater than or equal to 101° F for at least an hour, a low neutrophil count, and signs and symptoms of an infection such as tenderness or pain.

Not sure about your diagnosis?

Check Your Symptoms

What are the current treatments for Febrile Neutropenia?

Treatment for patients with febrile neutropenia depends on their overall condition. Treatments for febrile neutropenia include medications such as fluoroquinolone plus amoxicillin/clavulanate, clindamycin, cefepime, carbapenems, piperacillin, tazobactam, vancomycin, linezolid, daptomycin, polymyxin, colistin, tigecycline, triazole, trimethoprim-sulfamethoxazole, or a nucleoside reverse transcription inhibitor.

Who are the top Febrile Neutropenia Local Doctors?

Dr. Gary H. Lyman

Oncology | Hematology Oncology

Elite

Highly rated in

conditions

Oncology
Hematology Oncology

Seattle Cancer Care Alliance At South Lake Union

825 Eastlake Ave E,

Seattle, WA

Gary Lyman is an Oncologist and a Hematologist Oncology expert in Seattle, Washington. Lyman has been practicing medicine for over 51 years and is rated as an Elite expert by MediFind in the treatment of Febrile Neutropenia. He is also highly rated in 15 other conditions, according to our data. His top areas of expertise are Febrile Neutropenia, Agranulocytosis, Venous Thromboembolism (VTE), and Acquired Agranulocytosis. Lyman is currently accepting new patients.

Matti S. Aapro

Elite

Highly rated in

conditions

Clinique De Genolier

Genolier, CH

Matti Aapro practices in Genolier, Switzerland. Aapro is rated as an Elite expert by MediFind in the treatment of Febrile Neutropenia. They are also highly rated in 11 other conditions, according to our data. Their top areas of expertise are Febrile Neutropenia, Agranulocytosis, Acquired Agranulocytosis, Breast Cancer, and Bone Marrow Transplant.

Learn about our expert tiers

Learn more

Pere Gascon

Elite

Highly rated in

conditions

Hospital Clinic

Barcelona, ES

Pere Gascon practices in Barcelona, Spain. Gascon is rated as an Elite expert by MediFind in the treatment of Febrile Neutropenia. They are also highly rated in 9 other conditions, according to our data. Their top areas of expertise are Febrile Neutropenia, Agranulocytosis, Acquired Agranulocytosis, and Anemia.

View All Doctors

What are the latest Febrile Neutropenia Clinical Trials?

Fast-track Absolute Neutrophil Count in Suspected Neutropenic Fever (The FRANCiS-NF Trial): A Single-centre, Pragmatic, Open-label, Randomised, Controlled Trial

Enrollment Status: Recruiting

Publish Date: December 06, 2022

Intervention Type: Drug

Study Phase: Phase 4

Summary: This is a comparative study for adult participants with cancer who are suspected to have neutropenic fever (or fever with low neutrophil count) in emergency department. Neutrophil is a kind of defensive white blood cell combating against infection, especially by bacteria and fungi. Low neutrophil can be part of the disease progress or secondary to some cancer treatment. These participants are at h...

Match to trials

Find the right clinical trials for you in under a minute

Get started

Multiple Part Clinical Trial of Brentuximab Vedotin in Classical Hodgkin Lymphoma Subjects

Who is this study for: Child to adult patients with Hodgkin's Lymphoma

Enrollment Status: Active, not recruiting

Publish Date: December 06, 2022

Intervention Type: Drug

Study Drugs: BrentuximabDoxorubicinVinblastineDacarbazineNivolumabFilgrastim

Study Phase: Phase 2

Summary: This trial will study two treatment combinations for classical Hodgkin lymphoma (cHL). This trial will find out if these two treatment combinations work to treat cHL. It will also find out what side effects occur. A side effect is anything the drug does besides treating cancer. This study will have three parts (Parts A, B, and C). The drugs used in Part A are a combination of targeted anticancer d...

View All Clinical Trials

What are the Latest Advances for Febrile Neutropenia?